COPD-iNET: a call to the lung community for action to combat the global epidemic of COPD

Ali Önder Yildirim^{1

2}, Thomas M Conlon³, Ian M Adcock⁴, Reinoud Gosens⁵, Mareike Lehmann^{3

6}, Theodore S Kapellos^{3

2}, Yohannes Tesfaigzi⁷, Francesca Polverino⁸, Maor Sauler⁹, Roxana Wasnick³, Enid Rose Neptune¹⁰

Affiliations

¹ Institute of Lung Health and Immunity (LHI), Helmholtz Munich, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany oender.yildirim@helmholtz-munich.de.
² Institute of Experimental Pneumology, LMU, Munich, Germany.
³ Institute of Lung Health and Immunity (LHI), Helmholtz Munich, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany.
⁴ Respiratory Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK.
⁵ Department of Molecular Pharmacology, Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands.
⁶ Institute for Lung Research, Philipps-University Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany.
⁷ Pulmonary Critical Care Medicine Division, Mass General Brigham and Harvard Medical School, Harvard University, Boston, MA, USA.
⁸ Baylor College of Medicine Houston, Houston, TX, USA.
⁹ Pulmonary, Critical Care and Sleep Medicine, Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
¹⁰ Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine Baltimore, Baltimore, MD, USA.

Editorial

Ali Önder Yildirim et al. Eur Respir J. 2024.

. 2024 Sep 26;64(3):2400921.

doi: 10.1183/13993003.00921-2024. Print 2024 Sep.

¹ Institute of Lung Health and Immunity (LHI), Helmholtz Munich, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany oender.yildirim@helmholtz-munich.de.
² Institute of Experimental Pneumology, LMU, Munich, Germany.
³ Institute of Lung Health and Immunity (LHI), Helmholtz Munich, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany.
⁴ Respiratory Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK.
⁵ Department of Molecular Pharmacology, Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands.
⁶ Institute for Lung Research, Philipps-University Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany.
⁷ Pulmonary Critical Care Medicine Division, Mass General Brigham and Harvard Medical School, Harvard University, Boston, MA, USA.
⁸ Baylor College of Medicine Houston, Houston, TX, USA.
⁹ Pulmonary, Critical Care and Sleep Medicine, Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
¹⁰ Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine Baltimore, Baltimore, MD, USA.

No abstract available

Conflict of interest statement

Conflict of interest: The authors have no potential conflicts of interest to disclose.